Literature DB >> 11287345

Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia.

N J Philp1, H Yoon, L Lombardi.   

Abstract

Monocarboxylate transporters (MCTs) are a family of highly homologous membrane proteins that mediate the 1:1 transport of a proton and a lactate ion. In chicken, MCT3 is preferentially expressed in the retinal pigment epithelium (RPE). We have isolated the mouse MCT3 cDNA and gene and characterized the pattern of tissue expression. MCT3 is a single copy gene with a 1.8-kb transcript that encodes a protein with a predicted molecular mass of 51.5 kDa. Based on Northern hybridization analysis, MCT3 transcript was expressed in only two tissues: RPE and choroid plexus epithelium (CPE). The choroid plexus forms a barrier between the cerebrospinal fluid and fenestrated capillaries, similar to the organization of the RPE and choroidal vessels. Immunohistochemical staining demonstrated that MCT3 was restricted to the basolateral membranes of both epithelia but was more abundant in RPE than CPE. Differences in the level of protein expression were confirmed by Western blot analysis. The cloning of MCT3 identifies a specific transporter that could regulate lactate levels in fluid-bathing neuronal tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287345     DOI: 10.1152/ajpcell.2001.280.5.C1319

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  46 in total

1.  Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study.

Authors:  Chaim B Colen; Yimin Shen; Farhad Ghoddoussi; Pingyang Yu; Todd B Francis; Brandon J Koch; Michael D Monterey; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

Review 2.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Monocarboxylate Transporters: Therapeutic Targets and Prognostic Factors in Disease.

Authors:  R S Jones; M E Morris
Journal:  Clin Pharmacol Ther       Date:  2016-08-22       Impact factor: 6.875

4.  Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy.

Authors:  Susan D Vogt; Christine A Curcio; Lan Wang; Chuan-Ming Li; Gerald McGwin; Nancy E Medeiros; Nancy J Philp; James A Kimble; Russell W Read
Journal:  Exp Eye Res       Date:  2011-06-12       Impact factor: 3.467

Review 5.  Supply and demand in cerebral energy metabolism: the role of nutrient transporters.

Authors:  Ian A Simpson; Anthony Carruthers; Susan J Vannucci
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-20       Impact factor: 6.200

Review 6.  Brain metabolism in health, aging, and neurodegeneration.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  EMBO J       Date:  2017-04-24       Impact factor: 11.598

Review 7.  The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

Authors:  Andrew P Halestrap; David Meredith
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

8.  Energy metabolism of the visual system.

Authors:  Margaret T T Wong-Riley
Journal:  Eye Brain       Date:  2010-07-22

9.  The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.

Authors:  Matthew J Ovens; Christine Manoharan; Marieangela C Wilson; Clarey M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

10.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

Authors:  Matthew J Ovens; Andrew J Davies; Marieangela C Wilson; Clare M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.